SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile shares saw a sharp pullback after reporting first-quarter earnings that missed revenue and profit expectations, with community sentiment splitting between investors who believe long-term potential outweighs short-term execution hurdles and bears highlighting concerns over cash burn and launch delays. While the community is actively debating the company's ability to reach its year-end satellite deployment targets, bulls remain focused on reaffirmed guidance, new government contract awards, and the massive runway provided by current cash reserves.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is facing intense volatility following a mixed earnings report, where a bottom-line miss triggered a sharp sell-off while management's raised full-year guidance and expansion into peptide manufacturing provided a counter-narrative. The community remains deeply divided, with bulls pointing to long-term growth and platform scalability, while bears highlight margin pressure and intense competition as significant risks to the stock's future.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant attention as investors await the upcoming Phase 3 VELA-1 and VELA-2 dataset, which is viewed as a crucial catalyst to validate sonelokimab as a best-in-class treatment for inflammatory skin diseases. Community sentiment remains focused on the potential for institutional accumulation and long-term value, despite ongoing volatility and concerns regarding short interest and the timing of clinical trial readouts.

Billions is the global human and AI network, built on mobile-first verification to scale the internet of value. We uniquely verify the identity and uniqueness of humans and AI agents, empowering users with personalized experiences and rewards.  ‍Our network is designed to be accessible, scalable, and anonymous, making trust between humans and AI seamless and intuitive for everyone.

TillBilly

TillBilly is drawing significant attention as traders monitor its circulating supply and potential breakout momentum compared to other active tokens. The community is actively debating the coin's volatility, citing concerns over market manipulation and restricted exchange availability.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the B&W segment. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending as investors react to strong earnings and a massive project backlog, further fueled by speculation regarding high-profile AI data center partnerships and hyperscaler demand. Community discussion remains focused on the company's ability to capitalize on immediate off-grid power needs, with many highlighting recent contract momentum as a long-term catalyst despite previous volatility from short-seller reports.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is drawing significant attention as investors react to its recent quarterly results, balanced against ongoing concerns over cash burn and stock dilution. The community is actively debating the company's long-term commercial viability versus its speculative potential, with sentiment heavily influenced by broader sector momentum and volatile price action.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is experiencing a surge in trading volume and bullish sentiment following the live deployment of its Dirac-3 optimization machine on the Quantum Corridor network. Investors are actively discussing the stock's potential for a significant short squeeze and its long-term strategic shift toward commercializing photonic and edge-AI hardware, such as the NeuraWave platform, as a differentiator against larger quantum competitors.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant attention as investors speculate on its indirect exposure to highly anticipated pre-IPO companies like SpaceX and Anthropic. The community is actively debating the fund's net asset value versus its current market price, while simultaneously navigating concerns about recent prospectus filings, potential share dilution, and Anthropic's policies regarding special purpose vehicles.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin (CRO) is seeing heightened community discourse driven by anticipation around potential institutional catalysts and the upcoming launch of the Cronos app, while ongoing debates persist regarding tokenomics and historical dilution. Investors are actively tracking the project's ecosystem growth and the performance of native meme coins like $MERY as they search for signals of a broader recovery alongside the wider crypto market.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to a massive rebound following recent volatility, fueled by aggressive retail accumulation, speculation regarding potential new high-profile partnerships, and anticipation ahead of upcoming earnings. Community sentiment remains deeply divided, with bulls pointing to the company's photonics interposer technology as a critical AI infrastructure play, while skeptics emphasize persistent financial losses, management credibility concerns, and the risks associated with shareholder dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FTC Settlement With Cigna's Pharmacy Benefit Manager Promises Cheaper Insulin, Boosts Dividend On Strong Quarterly Earnings

FTC finalizes a settlement with Cigna's Express Scripts to curb insulin pricing practices, projecting $7 billion in patient savings as Cigna posts strong earnings and raises its dividend.read more...

ESRX
Express Scripts Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest ESRX News

ESRXExpress Scripts Inc.